Geode Capital Management
ITRM

Geode Capital Management’s Iterum Therapeutics ITRM Stock Holding History

Geode Capital Management’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,370
Closed -$4.14K – 4561
2025
Q4 		$4.14K Hold
12,370
– – ﹤0.01% 4457
2025
Q3 		$8.29K Hold
12,370
– – ﹤0.01% 4454
2025
Q2 		$12.3K Hold
12,370
– – ﹤0.01% 4412
2025
Q1 		$15.2K Hold
12,370
– – ﹤0.01% 4399
2024
Q4 		$21.9K Hold
12,370
– – ﹤0.01% 4374
2024
Q3 		$13.5K Buy
+12,370
New +$14.7K ﹤0.01% 4441
2022
Q3 		– Sell
-6,140
Closed -$18K – 5035
2022
Q2 		$18K Hold
6,140
– – ﹤0.01% 4936
2022
Q1 		$32K Buy
6,140
+3,932
+178% +$22.7K ﹤0.01% 4891
2021
Q4 		$12K Sell
2,208
-6,410
-74% -$49.5K ﹤0.01% 4963
2021
Q3 		$72K Buy
8,618
+1,878
+28% +$23.1K ﹤0.01% 4732
2021
Q2 		$233K Buy
6,740
+328
+5% +$7.11K ﹤0.01% 4280
2021
Q1 		$135K Buy
6,412
+4,204
+190% +$100K ﹤0.01% 4229
2020
Q4 		$32K Buy
+2,208
New +$25.8K ﹤0.01% 4218

Other funds holding ITRM

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
GWP
Gen-Wealth Partners Zeeland, Michigan $360M AUM 27.44% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management's ITRM Position: Q1 2026 in Review

Geode Capital Management sold out of Iterum Therapeutics (ITRM) in Q1 2026, closing a stake of 12,370 shares — an estimated $4.14K sold.

Geode Capital Management first reported a position in ITRM in Q4 2020 and held it in 13 quarters. The position peaked at $233K in Q2 2021. 18 funds tracked by Wall St. Rank hold ITRM as of Q1 2026.

  • Geode Capital Management reported no remaining Iterum Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Geode Capital Management sold 12,370 Iterum Therapeutics shares in Q1 2026, an estimated $4.14K.
  • Geode Capital Management first reported a position in Iterum Therapeutics in Q4 2020 and held it in 13 quarters.
  • Geode Capital Management's Iterum Therapeutics position peaked at $233K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.